Literature DB >> 7583932

Cytokines in the stools of children with complicated shigellosis.

T Azim1, R C Halder, M S Sarker, S Ahmed, J Hamadani, A Chowdhury, F Qadri, M A Salam, R B Sack, M J Albert.   

Abstract

The pathogenesis of the systemic complications, leukemoid reaction and hemolytic uremic syndrome, associated with Shigella dysenteriae type 1 infection is not well understood. The excessive production of proinflammatory cytokines, including tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6), has been suggested as a possible factor. We measured IL-6 and TNF-alpha in stools of 56 children with S. dysenteriae 1 infection and 29 children without any apparent infection, all age 12 to 60 months. Sixteen children with S. dysenteriae 1 infection had leukemoid reaction or hemolytic uremic syndrome (complicated shigellosis), while the others did not (uncomplicated shigellosis). Stool IL-6 and TNF-alpha concentrations were higher in children with uncomplicated shigellosis than in children with complicated shigellosis (P = 0.009 and < 0.001, respectively) or in uninfected children (P < 0.001). It is concluded that complicated infection is not associated with higher concentrations of the proinflammatory cytokines IL-6 and TNF-alpha in stool.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583932      PMCID: PMC170187          DOI: 10.1128/cdli.2.4.492-495.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  8 in total

1.  Shiga bacillus dysentery associated with marked leukocytosis and erythrocyte fragmentation.

Authors:  M M Rahaman; A K JamiulAlam; M R Islam; W B Greenough
Journal:  Johns Hopkins Med J       Date:  1975-02

2.  Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Authors:  R Raqib; A A Lindberg; B Wretlind; P K Bardhan; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

3.  Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea.

Authors:  S Nicholls; S Stephens; C P Braegger; J A Walker-Smith; T T MacDonald
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

4.  The leukemoid reaction in shigellosis.

Authors:  T Butler; M R Islam; P K Bardhan
Journal:  Am J Dis Child       Date:  1984-02

5.  Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection.

Authors:  D G de Silva; L N Mendis; N Sheron; G J Alexander; D C Candy; H Chart; B Rowe
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

6.  Tumour necrosis factor alpha in stool as a marker of intestinal inflammation.

Authors:  C P Braegger; S Nicholls; S H Murch; S Stephens; T T MacDonald
Journal:  Lancet       Date:  1992-01-11       Impact factor: 79.321

7.  Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon.

Authors:  T Hahn; Y Barak; E Liebovich; L Malach; O Dagan; E Rubinstein
Journal:  Exp Hematol       Date:  1991-03       Impact factor: 3.084

8.  Enteric protein loss during shigellosis.

Authors:  M L Bennish; M A Salam; M A Wahed
Journal:  Am J Gastroenterol       Date:  1993-01       Impact factor: 10.864

  8 in total
  7 in total

Review 1.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

2.  Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.

Authors:  K L Kotloff; F Noriega; G A Losonsky; M B Sztein; S S Wasserman; J P Nataro; M M Levine
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Immune response of children who develop persistent diarrhea following rotavirus infection.

Authors:  T Azim; S M Ahmad; M S Sarker; L E Unicomb; S De; J D Hamadani; M A Salam; M A Wahed; M J Albert
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

4.  Proinflammatory fecal mRNA and childhood bacterial enteric infections.

Authors:  William E Bennett; Rosbel González-Rivera; Bao N Puente; Nurmohammad Shaikh; Harold J Stevens; Jody C Mooney; Eileen J Klein; Donna M Denno; Andrew Draghi; Francisco A Sylvester; Phillip I Tarr
Journal:  Gut Microbes       Date:  2010-07-13

5.  Lipopolysaccharide-specific antibodies in plasma and stools of children with Shigella-associated leukemoid reaction and hemolytic-uremic syndrome.

Authors:  T Azim; F Qadri; S Ahmed; M S Sarker; R C Halder; J Hamadani; A Chowdhury; M A Wahed; M A Salam; M J Albert
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

6.  Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients.

Authors:  M Lorea Baroja; P V Kirjavainen; S Hekmat; G Reid
Journal:  Clin Exp Immunol       Date:  2007-06-22       Impact factor: 4.330

7.  Mucosal Immune Profiles Associated with Diarrheal Disease Severity in Shigella- and Enteropathogenic Escherichia coli-Infected Children Enrolled in the Global Enteric Multicenter Study.

Authors:  Amanda D Buskirk; Esther Ndungo; Avital A Shimanovich; Diana Lam; William C Blackwelder; Usman N Ikumapayi; Bing Ma; Helen Powell; Martin Antonio; James P Nataro; James B Kaper; Marcela F Pasetti
Journal:  mBio       Date:  2022-08-04       Impact factor: 7.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.